查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1225280

前列腺癌治療市場：2023-2028 年全球行業趨勢、份額、規模、增長、機遇和預測

Prostate Cancer Treatment Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
出版日期: | 出版商: IMARC | 英文 143 Pages | 商品交期: 2-3個工作天內

價格

2022 年全球前列腺癌治療市場規模將達到 72 億美元。 展望未來，IMARC Group 預計到 2028 年將達到 103 億美元，2023 年至 2028 年的增長率 (CAGR) 為 5.8%。

前列腺癌是男性前列腺內各種異常細胞不受控制地分裂擴張而引起的一種嚴重惡性腫瘤。 它可以通過使用各種治療方法來治療，包括疫苗、藥物和治療。 化學療法、免疫療法、冷凍療法、手術、激素療法、靶向療法和放射療法是阻止癌細胞在體內擴散的最常見療法。 這些治療是根據各種評估向患者提供的，包括患者的年齡、症狀的嚴重程度、醫療狀況和既往健康史。

前列腺癌藥物市場趨勢

  • 前列腺癌的患病率不斷上升，尤其是在老年人群中，這是目前推動市場增長的主要因素之一。 與此同時，有利的醫療報銷政策和各國政府機構推出患者援助計劃 (PAP) 的眾多舉措也是推動增長的因素。 PAP 是由製藥公司管理的一項有組織的計劃，通過免費提供用於治療目的的藥物來為患者提供經濟援助。 此外，在早期檢測前列腺癌的同時減少診斷錯誤，包括將多參數磁共振成像 (mp-MRI) 設備與非轉移性去勢抵抗 (nmCRPC) 和轉移性激素天然 (mHNPC) 設置相結合 重大技術進步在製造領域也為市場增長做出了貢獻。 此外，大力投資研發活動以推出新的治療產品，以及各種線上和線下分銷渠道的便捷供應，為市場創造了光明的前景。

主要市場細分

  • IMARC Group 分析了全球前列腺癌治療市場報告每個子細分市場的主要趨勢，並提供了 2023 年至 2028 年全球、區域和國家層面的預測。 該報告根據藥物類型和銷售渠道對市場進行分類。

按藥物類型細分

  • 化療
  • 生物療法
  • 激素療法
  • 其他

按銷售渠道細分

  • 醫院藥房
  • 藥店和零售店
  • 在線藥店

按地區劃分

  • 北美
  • 美國
  • 加拿大
  • 亞太地區
  • 中國
  • 日本
  • 印度
  • 韓國
  • 澳大利亞
  • 印度尼西亞
  • 其他
  • 歐洲
  • 德國
  • 法國
  • 英國
  • 意大利
  • 西班牙
  • 俄羅斯
  • 其他
  • 拉丁美洲
  • 巴西
  • 墨西哥
  • 其他
  • 中東和非洲

內容

第一章前言

第 2 章研究方法和範圍

  • 調查的目的
  • 利益相關者
  • 數據來源
    • 主要信息
    • 次要信息
  • 市場評估
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第 3 章執行摘要

第四章介紹

  • 概覽
  • 主要行業趨勢

第 5 章全球前列腺癌治療市場

  • 市場概覽
  • 市場結果
  • COVID-19 的影響
  • 市場預測

第 6 章按藥物類型劃分的市場細分

  • 化療
    • 市場趨勢
    • 市場預測
  • 生物製劑
    • 市場趨勢
    • 市場預測
  • 激素療法
    • 市場趨勢
    • 市場預測
  • 其他
    • 市場趨勢
    • 市場預測

第 7 章分銷渠道市場細分

  • 醫院藥房
    • 市場趨勢
    • 市場預測
  • 藥店/藥房
    • 市場趨勢
    • 市場預測
  • 在線藥店
    • 市場趨勢
    • 市場展望

第 8 章按區域劃分的市場細分

  • 北美
    • 美國
      • 市場趨勢
      • 市場預測
    • 加拿大
      • 市場趨勢
      • 市場展望
  • 亞太地區
    • 中國
      • 市場趨勢
      • 市場展望
    • 日本
      • 市場趨勢
      • 市場預測
    • 印度
      • 市場趨勢
      • 市場展望
    • 韓國市場
      • 市場趨勢
      • 市場展望
    • 澳大利亞
      • 市場趨勢
      • 市場展望
    • 印度尼西亞
      • 市場趨勢
      • 市場展望
    • 其他
      • 市場趨勢
      • 市場預測
  • 歐洲
    • 德國
      • 市場趨勢
      • 市場展望
    • 法國
      • 市場趨勢
      • 市場預測
    • 英國
      • 市場趨勢
      • 市場預測
    • 意大利
      • 市場趨勢
      • 市場展望
    • 西班牙
      • 市場趨勢
      • 市場展望
    • 俄羅斯
      • 市場趨勢
      • 市場展望
    • 其他
      • 市場趨勢
      • 市場預測
  • 拉丁美洲
    • 巴西
      • 市場趨勢
      • 市場展望
    • 墨西哥
      • 市場趨勢
      • 市場展望
    • 其他
      • 市場趨勢
      • 市場預測
  • 中東和非洲
    • 市場趨勢
    • 按國家/地區劃分的市場細分
    • 市場展望

第9章SWOT分析

  • 概覽
  • 強度
  • 弱點
  • 機會
  • 威脅

第 10 章價值鏈分析

第11章波特五力分析

  • 概覽
  • 買家的議價能力
  • 供應商的議價能力
  • 競爭程度
  • 新進入者的威脅
  • 替代品的威脅

第 12 章：價格分析

第13章競爭格局

  • 市場結構
  • 主要公司
  • 主要公司簡介
    • Astellas Pharma Inc.
    • AstraZeneca plc
    • Bayer Aktiengesellschaft
    • Dendreon Pharmaceuticals LLC.（Sanpower Group Co. Ltd.）
    • F. Hoffmann-La Roche AG
    • Ferring B.V.
    • GlaxoSmithKline Plc
    • Ipsen（Mayroy SA）
    • Novartis International AG
    • Takeda Pharmaceutical Company Ltd.
    • Tolmar Pharmaceuticals Inc.
Product Code: SR1423A121_Report

The global prostate cancer treatment market size reached US$ 7.2 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 10.3 Billion by 2028, exhibiting a growth rate (CAGR) of 5.8% during 2023-2028.

Prostate cancer is a type of severe malignant tumor, which is caused by the uncontrollable division and expansion of various abnormal cells in the prostate gland present in men. It can be treated through the use of various therapeutics, such as vaccines, medications, and treatments. Amongst these, chemotherapy, immunotherapy, cryotherapy, surgery, hormonal, targeted and radiation therapy are some of the most common treatment types that aid in mitigating the spread of cancer cells in the body. These therapies are provided to the patient based on various assessments, such as the age of the patient, severity of the symptoms experienced, medical condition, and previous health history.

Prostate Cancer Treatment Market Trends:

  • The increasing prevalence of prostate cancer, especially amongst the rising geriatric population, is one of the prime factors currently driving the market toward growth. In line with this, the availability of favorable medical reimbursement policies and the numerous initiatives being undertaken by the government bodies of several countries for introducing patient assistance programs (PAPs) are acting as other growth-inducing factors. PAP is an organized program, which is controlled by pharmaceutical companies for providing financial assistance to patients by offering free medications for treatment purposes. Moreover, significant technological advancements, such as the integration of multiparametric-magnetic resonance imaging (mp-MRI) devices with non-metastatic castration-resistant (nmCRPC) and metastatic hormone nave (mHNPC) settings for detecting prostate cancer at early stages, while mitigating diagnostic errors, is also contributing to the market growth. Additionally, extensive investments in the research and development (R&D) activities to introduce novel therapeutic products, along with their easy availability across various online and offline distribution channels, are creating a positive outlook for the market.

Key Market Segmentation:

  • IMARC Group provides an analysis of the key trends in each sub-segment of the global prostate cancer treatment market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on drug type and distribution channel.

Breakup by Drug Type:

  • Chemotherapy
  • Biological Therapy
  • Hormone Therapy
  • Others

Breakup by Distribution Channel:

  • Hospitals Pharmacies
  • Drug Stores and Retail Pharmacies
  • Online Pharmacies

Breakup by Region:

  • North America
  • United States
  • Canada
  • Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa

Competitive Landscape:

  • The competitive landscape of the industry has also been examined along with the profiles of the key players being Astellas Pharma Inc., AstraZeneca plc, Bayer Aktiengesellschaft, Dendreon Pharmaceuticals LLC. (Sanpower Group Co. Ltd.), F. Hoffmann-La Roche AG, Ferring B.V., GlaxoSmithKline Plc, Ipsen (Mayroy SA), Novartis International AG, Takeda Pharmaceutical Company Ltd. and Tolmar Pharmaceuticals Inc.
  • Key Questions Answered in This Report
  • 1. What was the size of the global prostate cancer treatment market in 2022?
  • 2. What is the expected growth rate of the global prostate cancer treatment market during 2023-2028?
  • 3. What are the key factors driving the global prostate cancer treatment market?
  • 4. What has been the impact of COVID-19 on the global prostate cancer treatment market?
  • 5. What is the breakup of the global prostate cancer treatment market based on drug type?
  • 6. What is the breakup of the global prostate cancer treatment market based on the distribution channel?
  • 7. What are the key regions in the global prostate cancer treatment market?
  • 8. Who are the key players/companies in the global prostate cancer treatment market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Prostate Cancer Treatment Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Drug Type

  • 6.1 Chemotherapy
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Biological Therapy
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Hormone Therapy
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Others
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast

7 Market Breakup by Distribution Channel

  • 7.1 Hospitals Pharmacies
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Drug Stores and Retail Pharmacies
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Online Pharmacies
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast

8 Market Breakup by Region

  • 8.1 North America
    • 8.1.1 United States
      • 8.1.1.1 Market Trends
      • 8.1.1.2 Market Forecast
    • 8.1.2 Canada
      • 8.1.2.1 Market Trends
      • 8.1.2.2 Market Forecast
  • 8.2 Asia-Pacific
    • 8.2.1 China
      • 8.2.1.1 Market Trends
      • 8.2.1.2 Market Forecast
    • 8.2.2 Japan
      • 8.2.2.1 Market Trends
      • 8.2.2.2 Market Forecast
    • 8.2.3 India
      • 8.2.3.1 Market Trends
      • 8.2.3.2 Market Forecast
    • 8.2.4 South Korea
      • 8.2.4.1 Market Trends
      • 8.2.4.2 Market Forecast
    • 8.2.5 Australia
      • 8.2.5.1 Market Trends
      • 8.2.5.2 Market Forecast
    • 8.2.6 Indonesia
      • 8.2.6.1 Market Trends
      • 8.2.6.2 Market Forecast
    • 8.2.7 Others
      • 8.2.7.1 Market Trends
      • 8.2.7.2 Market Forecast
  • 8.3 Europe
    • 8.3.1 Germany
      • 8.3.1.1 Market Trends
      • 8.3.1.2 Market Forecast
    • 8.3.2 France
      • 8.3.2.1 Market Trends
      • 8.3.2.2 Market Forecast
    • 8.3.3 United Kingdom
      • 8.3.3.1 Market Trends
      • 8.3.3.2 Market Forecast
    • 8.3.4 Italy
      • 8.3.4.1 Market Trends
      • 8.3.4.2 Market Forecast
    • 8.3.5 Spain
      • 8.3.5.1 Market Trends
      • 8.3.5.2 Market Forecast
    • 8.3.6 Russia
      • 8.3.6.1 Market Trends
      • 8.3.6.2 Market Forecast
    • 8.3.7 Others
      • 8.3.7.1 Market Trends
      • 8.3.7.2 Market Forecast
  • 8.4 Latin America
    • 8.4.1 Brazil
      • 8.4.1.1 Market Trends
      • 8.4.1.2 Market Forecast
    • 8.4.2 Mexico
      • 8.4.2.1 Market Trends
      • 8.4.2.2 Market Forecast
    • 8.4.3 Others
      • 8.4.3.1 Market Trends
      • 8.4.3.2 Market Forecast
  • 8.5 Middle East and Africa
    • 8.5.1 Market Trends
    • 8.5.2 Market Breakup by Country
    • 8.5.3 Market Forecast

9 SWOT Analysis

  • 9.1 Overview
  • 9.2 Strengths
  • 9.3 Weaknesses
  • 9.4 Opportunities
  • 9.5 Threats

10 Value Chain Analysis

11 Porters Five Forces Analysis

  • 11.1 Overview
  • 11.2 Bargaining Power of Buyers
  • 11.3 Bargaining Power of Suppliers
  • 11.4 Degree of Competition
  • 11.5 Threat of New Entrants
  • 11.6 Threat of Substitutes

12 Price Analysis

13 Competitive Landscape

  • 13.1 Market Structure
  • 13.2 Key Players
  • 13.3 Profiles of Key Players
    • 13.3.1 Astellas Pharma Inc.
      • 13.3.1.1 Company Overview
      • 13.3.1.2 Product Portfolio
      • 13.3.1.3 Financials
      • 13.3.1.4 SWOT Analysis
    • 13.3.2 AstraZeneca plc
      • 13.3.2.1 Company Overview
      • 13.3.2.2 Product Portfolio
      • 13.3.2.3 Financials
      • 13.3.2.4 SWOT Analysis
    • 13.3.3 Bayer Aktiengesellschaft
      • 13.3.3.1 Company Overview
      • 13.3.3.2 Product Portfolio
      • 13.3.3.3 Financials
      • 13.3.3.4 SWOT Analysis
    • 13.3.4 Dendreon Pharmaceuticals LLC. (Sanpower Group Co. Ltd.)
      • 13.3.4.1 Company Overview
      • 13.3.4.2 Product Portfolio
    • 13.3.5 F. Hoffmann-La Roche AG
      • 13.3.5.1 Company Overview
      • 13.3.5.2 Product Portfolio
      • 13.3.5.3 Financials
    • 13.3.6 Ferring B.V.
      • 13.3.6.1 Company Overview
      • 13.3.6.2 Product Portfolio
    • 13.3.7 GlaxoSmithKline Plc
      • 13.3.7.1 Company Overview
      • 13.3.7.2 Product Portfolio
      • 13.3.7.3 Financials
      • 13.3.7.4 SWOT Analysis
    • 13.3.8 Ipsen (Mayroy SA)
      • 13.3.8.1 Company Overview
      • 13.3.8.2 Product Portfolio
      • 13.3.8.3 Financials
      • 13.3.8.4 SWOT Analysis
    • 13.3.9 Novartis International AG
      • 13.3.9.1 Company Overview
      • 13.3.9.2 Product Portfolio
      • 13.3.9.3 Financials
      • 13.3.9.4 SWOT Analysis
    • 13.3.10 Takeda Pharmaceutical Company Ltd.
      • 13.3.10.1 Company Overview
      • 13.3.10.2 Product Portfolio
      • 13.3.10.3 Financials
      • 13.3.10.4 SWOT Analysis
    • 13.3.11 Tolmar Pharmaceuticals Inc.
      • 13.3.11.1 Company Overview
      • 13.3.11.2 Product Portfolio

List of Figures

  • Figure 1: Global: Prostate Cancer Treatment Market: Major Drivers and Challenges
  • Figure 2: Global: Prostate Cancer Treatment Market: Sales Value (in Billion US$), 2017-2022
  • Figure 3: Global: Prostate Cancer Treatment Market Forecast: Sales Value (in Billion US$), 2023-2028
  • Figure 4: Global: Prostate Cancer Treatment Market: Breakup by Drug Type (in %), 2022
  • Figure 5: Global: Prostate Cancer Treatment Market: Breakup by Distribution Channel (in %), 2022
  • Figure 6: Global: Prostate Cancer Treatment Market: Breakup by Region (in %), 2022
  • Figure 7: Global: Prostate Cancer Treatment (Chemotherapy) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 8: Global: Prostate Cancer Treatment (Chemotherapy) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 9: Global: Prostate Cancer Treatment (Biological Therapy) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 10: Global: Prostate Cancer Treatment (Biological Therapy) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 11: Global: Prostate Cancer Treatment (Hormone Therapy) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 12: Global: Prostate Cancer Treatment (Hormone Therapy) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 13: Global: Prostate Cancer Treatment (Other Drug Types) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 14: Global: Prostate Cancer Treatment (Other Drug Types) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 15: Global: Prostate Cancer Treatment (Hospitals Pharmacies) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 16: Global: Prostate Cancer Treatment (Hospitals Pharmacies) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 17: Global: Prostate Cancer Treatment (Drug Stores and Retail Pharmacies) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 18: Global: Prostate Cancer Treatment (Drug Stores and Retail Pharmacies) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 19: Global: Prostate Cancer Treatment (Online Pharmacies) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 20: Global: Prostate Cancer Treatment (Online Pharmacies) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 21: North America: Prostate Cancer Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 22: North America: Prostate Cancer Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 23: United States: Prostate Cancer Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 24: United States: Prostate Cancer Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 25: Canada: Prostate Cancer Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 26: Canada: Prostate Cancer Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 27: Asia-Pacific: Prostate Cancer Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 28: Asia-Pacific: Prostate Cancer Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 29: China: Prostate Cancer Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 30: China: Prostate Cancer Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 31: Japan: Prostate Cancer Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 32: Japan: Prostate Cancer Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 33: India: Prostate Cancer Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 34: India: Prostate Cancer Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 35: South Korea: Prostate Cancer Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 36: South Korea: Prostate Cancer Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 37: Australia: Prostate Cancer Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 38: Australia: Prostate Cancer Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 39: Indonesia: Prostate Cancer Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 40: Indonesia: Prostate Cancer Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 41: Others: Prostate Cancer Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 42: Others: Prostate Cancer Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 43: Europe: Prostate Cancer Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 44: Europe: Prostate Cancer Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 45: Germany: Prostate Cancer Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 46: Germany: Prostate Cancer Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 47: France: Prostate Cancer Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 48: France: Prostate Cancer Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 49: United Kingdom: Prostate Cancer Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 50: United Kingdom: Prostate Cancer Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 51: Italy: Prostate Cancer Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 52: Italy: Prostate Cancer Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 53: Spain: Prostate Cancer Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 54: Spain: Prostate Cancer Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 55: Russia: Prostate Cancer Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 56: Russia: Prostate Cancer Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 57: Others: Prostate Cancer Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 58: Others: Prostate Cancer Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 59: Latin America: Prostate Cancer Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 60: Latin America: Prostate Cancer Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 61: Brazil: Prostate Cancer Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 62: Brazil: Prostate Cancer Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 63: Mexico: Prostate Cancer Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 64: Mexico: Prostate Cancer Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 65: Others: Prostate Cancer Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 66: Others: Prostate Cancer Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 67: Middle East and Africa: Prostate Cancer Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 68: Middle East and Africa: Prostate Cancer Treatment Market: Breakup by Country (in %), 2022
  • Figure 69: Middle East and Africa: Prostate Cancer Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 70: Global: Prostate Cancer Treatment Industry: SWOT Analysis
  • Figure 71: Global: Prostate Cancer Treatment Industry: Value Chain Analysis
  • Figure 72: Global: Prostate Cancer Treatment Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Prostate Cancer Treatment Market: Key Industry Highlights, 2022 and 2028
  • Table 2: Global: Prostate Cancer Treatment Market Forecast: Breakup by Drug Type (in Million US$), 2023-2028
  • Table 3: Global: Prostate Cancer Treatment Market Forecast: Breakup by Distribution Channel (in Million US$), 2023-2028
  • Table 4: Global: Prostate Cancer Treatment Market Forecast: Breakup by Region (in Million US$), 2023-2028
  • Table 5: Global: Prostate Cancer Treatment Market: Competitive Structure
  • Table 6: Global: Prostate Cancer Treatment Market: Key Players